News
Delivered as a once-daily 30 mg/mL IV bolus injection over 15 seconds, Xifyrm can be used alone or alongside non-NSAID ...
Abbott signs groundbreaking psychedelic research bill to help bring ibogaine through clinical trials
The Texas governor signed a $50 million bill into law on Wednesday to help bring ibogaine through FDA-approved clinical ...
Advocates said the legislation, signed by Gov. Greg Abbott on Wednesday, is the largest state-funded psychedelic research ...
Final enrollment concludes for Spark Biomedical's pivotal study investigating a non-invasive, drug-free neurostimulation ...
A rare genetic disorder known as Neurofibromatosis type one, or NF1, affects about one in 2,500 people in the U.S.
Senate Bill 2308, signed by Gov. Abbott, makes Texas a national leader in ibogaine research for PTSD and opioid treatment, ...
In a landmark case in Tarrant County, a jury convicted a man of murder for supplying illegal drugs that resulted in a fatal ...
The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...
Board-certified nurse practitioner and recognized authority on addiction recovery, is calling for a shift in medical ...
Backed by a $1 million grant, the Cook County van will bring critical opioid treatment directly to more than two dozen south ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results